Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 581 posts found.

PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies

April 25, 2023
Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company, noted today that its Founded …

News
Press release

Brain scanning technology to be used for clinical psychedelics trials in pioneering London start-up partnership

April 25, 2023
Business Services

London, UK: Commercial trials for psychedelics-assisted medical treatments will now have access to state-of-the-art brain scanning technology thanks to a …

News
Press release

Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference

April 25, 2023
Business Services

Cambridge, UK, April 25, 2023 – Alchemab Therapeutics, an antibody discovery company identifying naturally occurring antibodies from individuals resilient to …

News
Press release

National Institute for Health and Care Excellence recommends Darzalex® (daratumumab) with bortezomib and dexamethasone for routine use on the NHS as treatment for multiple myeloma

April 24, 2023
Business Services

High Wycombe, 24 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson are pleased to announce that the …

News
Press release

Sphere Fluidics begins work with partners on 3DSecret program to investigate mechanisms of metastasis in cancer

April 24, 2023
Business Services

Cambridge, UK, 24th April 2023: Sphere Fluidics, a company developing single cell analysis systems underpinned by its patented picodroplet technology, …

News
Press release

Incyte Announces European Commission Approval of Opzelura® (ruxolitinib) Cream for the Treatment of Non-Segmental Vitiligo with Facial Involvement in Adults and Adolescents

April 24, 2023
Business Services

WILMINGTON, Del. – April 20, 2023 – Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has granted a marketing …

News
Press release

Janssen Marks First Approval Worldwide for AKEEGA® (Niraparib and Abiraterone Acetate Dual Action Tablet) with EC Authorisation for the Treatment of Patients with Metastatic Castration Resistant Prostate Cancer with BRCA1/2 Mutations

April 24, 2023
Business Services

BEERSE, Belgium, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the European Commission …

News
Press release

NICE gives green light to ibrutinib plus venetoclax as first-line treatment option for chronic lymphocytic leukaemia

April 24, 2023
Business Services

High Wycombe, 21 April 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson is pleased to announce that the …

News
Press release

Breye Therapeutics Strengthens Management Team and Board

April 20, 2023
Business Services

Copenhagen, Denmark, 20 April 2023 – Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing novel oral therapies for retinal …

News
Press release

Elsevier launches EmBiology to deliver the unparalleled insights into biological activities that accelerate drug discovery

April 19, 2023
Business Services

New York, April 19, 2023 – Elsevier, a leader in global information analytics, has launched EmBiology, a research tool that …

News
Press release

Veeva MedTech Clinical Trials Report Signals Significant Opportunity to Improve Data Delivery and Quality

April 19, 2023
Business Services

BARCELONA, Spain — 19 Apr. 2023 — Veeva Systems (NYSE: VEEV) today released its first-ever report examining global trends in …

News
Press release

Growth in global demand for pure medical cannabis sees Lesotho-based cultivator and manufacturer expand its production

April 19, 2023
Business Services

19 April 2023, Maseru – Licensed cultivator and manufacturer of medical-grade cannabis extracts and products,

News
Press release

Revolo Biotherapeutics Announces Positive Topline Data from Phase 2a Trial of ‘1104 in Adults with Active Eosinophilic Esophagitis

April 19, 2023
Business Services

NEW ORLEANS and CAMBRIDGE, UK, April 19 2023 – Revolo Biotherapeutics (“Revolo” or the “Company”), a company developing therapies that …

News
Press release

Oxford BioTherapeutics announces Phase 1b trial in collaboration with GORTEC to investigate OBT076 in Adenoid Cystic Carcinoma (ACC) of the head and neck

April 19, 2023
Business Services

Oxford, UK and San Jose, Calif., 19 April 2023 – Oxford BioTherapeutics Ltd.

News
Press release

OWEN MUMFORD WINS DISTINCTION IN RED DOT AWARD (PRODUCT DESIGN 2023) FOR AIDAPTUS® AUTO-INJECTOR

April 18, 2023
Business Services

OXFORD, England, 18 April 2023 – Owen Mumford is proud to have been awarded a distinction in the prestigious Red …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025